<DOC>
	<DOCNO>NCT01779310</DOCNO>
	<brief_summary>There guideline management AD China , evidence adopt guideline mostly trial conduct country due limited Chinese data available local systematic review . Therefore , local evidence dementia care need development evidence-based guideline appropriate people live China . Meanwhile , inadequate implementation current AD guideline , result low diagnostic rate high diagnostic leakage , may bring extra barrier AD patient access dementia care service different area nationwide . However , data clinical pathway physician follow dementia guideline routine practice . Therefore , research need learn clinical diagnostic process treatment pattern physicians people AD routine practice help address low accurate rate AD clinical diagnosis low anti-dementia drug prescription real world support guideline development .</brief_summary>
	<brief_title>Clinical Pathway Alzheimer 's Disease China ( CPAD )</brief_title>
	<detailed_description>Outpatients visit memory clinic judge physician clinically significant cognitive impairment invite join study study recruit period ( informed consent sign ) . - Patients enrol study evaluate diagnosed participate physician may may prescribe therapy ( pharmaceutical and/or non-pharmaceutical ) base physician ' medical judgment . - For patient routine clinical follow-up visit , medical chart review documentation . The procedure make diagnosis develop treatment scheme retrieve documented clinical report form ( CRF ) . Additional procedure order participate physician current visit also document CRF . All participant follow twice baseline visit re-evaluate confirm initial diagnosis ( applicable ) , record compliance treatment scheme , include process medication titration . This study recommend restrict specific treatment .</detailed_description>
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Dementia</mesh_term>
	<mesh_term>Mild Cognitive Impairment</mesh_term>
	<criteria>Male female outpatient clinically significant cognitive impairment per independent judgment participate physician ; Aged 45 year old ; Willing receive 2 followup visit ; Having least one informant caregiver accompany visit ; Willing join study sign inform consent prior study . Cognitive impairment likely identify secondary disease condition ( ) AD ( include limit stroke , Parkinson 's disease , brain trauma , central nervous system infection , etc . ) Unwilling participate study ; Participating study registry study period .</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
</DOC>